A Study of TL-925 for the Treatment of Allergic Conjunctivitis
Clinical trial NCT06153342 · UNKNOWN
Trial details
- NCT number
- NCT06153342
- Sponsor
- Telios Pharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2024-01-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.